About
Technology
Issues
FAQ
Links
Official Page
Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.